Methenamine/Hyoscyamine (Discontinued)

DEA Class;  Rx

Common Brand Names; Prosed DS, Darpaz, Urogesic Blue

  • Antibiotics, Other

Methenamine: Hydrolyzed in acidic urine to ammonia and formaldehyde, which are bactericidal agents; does not convert to formaldehyde in serum

Hyoscyamine: Elicits anticholinergic activity; decreases urinary spasms with cystitis

Additional ingredients in some products: Methylene blue (weak antiseptic properties); sodium phosphate monobasic (acidifier); phenyl salicylate (mild analgesic)

Use only after eradication of UTI by other appropriate antibiotic

Methenamine: Indicated for prophylaxis/suppression for chronic recurring UTIs when long-term therapy is required

Hyoscyamine: Adjunctive treatment for lower urinary tract hypermotility and spasm

Methenamine

  • Hypersensitivity to methenamine or tartrazine (FD&C Yellow No. 5)

  • Renal or severe hepatic insufficiency

  • Concurrent sulfonamides or acetazolamide may form insoluble precipitate in urine

Hyoscyamine

  • Hypersensitivity to hyoscyamine or related compounds

  • Closed-angle glaucoma, myasthenia gravis, hemorrhage w/ cardiovascular instability, paralytic ileus, intestinal atony of elderly/debilitated pt, obstructive uropathy, toxic megacolon, GI obstruction, tachycardia secondary to cardiac insufficiency or thyrotoxicosis

  • Breastfeeding

  • Dry skin
  • Dysuria
  • Discoloration of urine (blue)
  • Gastric upset
  • Nausea
  • Rash
  • Blurred vision
  • Constipation
  • Dysphagia
  • Photosensitivity

Methenamine

  • Large doses may cause bladder irritation, urinary frequency, albuminuria, and hematuria

  • Maintain acidic pH of urine, esp. when treating urea-splitting organisms (eg, Proteus, Pseudomonas)

  • Monitor LFTs, especially with history of liver impairment

  • Safe use not established during pregnancy, especially 1st and 2nd trimester

  • May precipitate uric acid stones in patients with gout

Hyoscyamine

  • Renal/hepatic impairment, BPH, CHF, CAD, HTN, COPD, hiatal hernia, reflux esophagitis, mitral stenosis, brain damage or spastic paralysis in children, salivary secretion disorder, Down syndrome, autonomic neuropathy, hyperthyroidism, tachyarrythmia, toxin-mediated diarrhea

  • Elderly

Pregnancy Category: C

Lactation: hyoscyamine and methenamine excreted in human milk; caution in breastfeeding women

Adult

1 tablet/capsule PO q6hr with liberal fluid intake

Pediatric

<16 years: Safety/efficacy not established

≥16 years: 1 tablet/capsule PO q6hr with liberal fluid intake

Geriatric

Avoid hyoscyamine except in short-term situations to decrease secretions; high incidence of anticholinergic effects (Beers criteria)

Methenamine/Hyoscyamine

tablet

  • 81mg/0.12mg

tablet, capsule

  • 120mg/0.12mg

About the Author

You may also like these

0